Inventor · disambiguated record
Barbara P. Wallner
Also filed as: WALLNER BARBARA · WALLNER BARBARA P
34 granted patents·10 pending applications·1,307 citations·filing 1985–2018
98Inventor score
Files withBIOGEN INC16POINT THERAPEUTICS INC14ZIOPHARM ONCOLOGY INC5WALLNER BARBARA P4AMEDIO JR JOHN C1
Top patents by PatentIndex Score
44 records- 0196US6703238B2Methods for expanding antigen-specific T cellsPOINT THERAPEUTICS INC·Filed 2001·Granted Mar 9, 2004·65 cites·19 claims
- 0295US7282484B2Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2006·Granted Oct 16, 2007·14 cites·12 claims
- 0395US6162432AMethod of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interactionBIOGEN INC·Filed 1995·Granted Dec 19, 2000·159 cites·55 claims
- 0494US7259138B2Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2005·Granted Aug 21, 2007·11 cites·10 claims
- 0594US6890904B1Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2000·Granted May 10, 2005·85 cites·64 claims
- 0693US6949514B2Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2003·Granted Sep 27, 2005·43 cites·52 claims
- 0793US6300314B1Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 1999·Granted Oct 9, 2001·106 cites·36 claims
- 0893US6258597B1Stimulation of hematopoietic cells in vitroPOINT THERAPEUTICS INC·Filed 1998·Granted Jul 10, 2001·123 cites·20 claims
- 0991US6764681B2Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interactionBIOGEN INC·Filed 2000·Granted Jul 20, 2004·39 cites·57 claims
- 1090US6770628B2Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 2001·Granted Aug 3, 2004·34 cites·21 claims
- 1190US6355614B1Cyclic boroproline compoundsPOINT THERAPEUTICS·Filed 1999·Granted Mar 12, 2002·113 cites·8 claims
- 1290US5547853ACD2-binding domain of lymphocyte function associated antigen 3BIOGEN INC·Filed 1992·Granted Aug 20, 1996·66 cites·35 claims
- 1390US4956281ADNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3BIOGEN INC·Filed 1987·Granted Sep 11, 1990·108 cites·10 claims
- 1488US5223394ARecombinant dna molecule comprising lymphocyte function-associated antigen 3 phosphatidylinositol linkage signal sequenceBIOGEN INC·Filed 1989·Granted Jun 29, 1993·63 cites·15 claims
- 1586US7323171B2Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interactionASTELLAS US LLC·Filed 2004·Granted Jan 29, 2008·25 cites·68 claims
- 1686US7265118B2Regulation of substrate activityPOINT THERAPEUTICS INC·Filed 2005·Granted Sep 4, 2007·3 cites·5 claims
- 1783US7067489B2Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 2004·Granted Jun 27, 2006·14 cites·16 claims
- 1882US4879224ADNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptidesBIOGEN INC·Filed 1985·Granted Nov 7, 1989·44 cites·9 claims
- 1981US7276371B2Stimulation of hematopoietic cells in vitroPOINT THERAPEUTICS INC·Filed 2003·Granted Oct 2, 2007·8 cites·7 claims
- 2076US5914111ACD2-binding domain of lymphocyte function associated antigen-3BIOGEN INC·Filed 1995·Granted Jun 22, 1999·30 cites·6 claims
- 2174US5928643AMethod of using CD2-binding domain of lymphocyte function associated antigen 3 to initiate T cell activationBIOGEN INC·Filed 1995·Granted Jul 27, 1999·24 cites·4 claims
- 2273US8252773B2Combination therapy with organic arsenicalsWALLNER BARBARA P·Filed 2008·Granted Aug 28, 2012·2 cites·15 claims
- 2369US5484711ADNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VIBIOGEN INC·Filed 1993·Granted Jan 16, 1996·18 cites·8 claims
- 2468US5728677AMethods of inhibiting T-cell dependent proliferation of peripheral blood lymphocytes using the CD2-binding domain of lymphocyte function associated antigen 3BIOGEN INC·Filed 1995·Granted Mar 17, 1998·20 cites·9 claims
- 2568US2008241274A1Indibulin therapyZIOPHARM ONCOLOGY INC·Filed 2007·Application pending·0 cites
- 2666US6979697B1Regulation of substrate activityPOINT THERAPEUTICS INC·Filed 1999·Granted Dec 27, 2005·23 cites·15 claims
- 2763US2008221068A1Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 2863US2014193519A1Indibulin therapyZIOPHARM ONCOLOGY INC·Filed 2013·Application pending·0 cites
- 2961US2013084345A1Indibulin therapyZIOPHARM ONCOLOGY INC·Filed 2012·Application pending·0 cites
- 3058US2007135354A1Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3157US5185441ADna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3BIOGEN INC·Filed 1988·Granted Feb 9, 1993·16 cites·15 claims
- 3256US9340563B2Salts of isophosphoramide mustard and analogs thereofZIOPHARM ONCOLOGY INC·Filed 2013·Granted May 17, 2016·0 cites·8 claims
- 3356US5081019ADNA sequences, recombinant DNA molecules and processes for producing lipocortin-like polypeptidesBIOGEN INC·Filed 1990·Granted Jan 14, 1992·14 cites·9 claims
- 3454US8604007B2Salts of isophosphoramide mustard and analogs thereofAMEDIO JR JOHN C·Filed 2008·Granted Dec 10, 2013·0 cites·29 claims
- 3553US5298489ADNA sequences recombinant DNA molecules and processes for producing lipocortins III, IV, V and VIBIOGEN INC·Filed 1991·Granted Mar 29, 1994·8 cites·5 claims
- 3652US2013261082A1Combination Therapy With Organic ArsenicalsZIOPHARM ONCOLOGLY INC·Filed 2013·Application pending·0 cites
- 3750US2014004192A1Pharmaceutical formulations of indibulin and uses thereofZIOPHARM ONCOLOGY INC·Filed 2013·Application pending·0 cites
- 3849US4950646ADNA sequences, recombinant DNA molecules and processes for producing human lipocortin-like polypeptidesBIOGEN INC·Filed 1986·Granted Aug 21, 1990·14 cites·5 claims
- 3949US4874743ADNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor-like polypeptidesBIOGEN INC·Filed 1985·Granted Oct 17, 1989·13 cites·9 claims
- 4049US2006084107A1Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interactionWALLNER BARBARA P·Filed 2005·Application pending·0 cites
- 4148US2012295861A1Combination Therapy With Organic ArsenicalsWALLNER BARBARA P·Filed 2012·Application pending·0 cites
- 4244US2021161902A1Epichaperome inhibitor therapy for traumatic brain injury and sequelae thereofSAMUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4343US8796329B2Method for controlling angiogenesis in animalsWALLNER BARBARA P·Filed 2007·Granted Aug 5, 2014·0 cites·20 claims
- 4439US5354665ARecombinant DNA processes for producing PI-linked lymphocyte function associated antigen-3BIOGEN INC·Filed 1992·Granted Oct 11, 1994·2 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Barbara P. Wallner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →